for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zhejiang Shouxiangu Pharmaceuticl Co Ltd

603896.SS

Latest Trade

36.21CNY

Change

-0.42(-1.15%)

Volume

591,700

Today's Range

36.05

 - 

36.68

52 Week Range

29.62

 - 

48.88

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
36.63
Open
36.49
Volume
591,700
3M AVG Volume
20.21
Today's High
36.68
Today's Low
36.05
52 Week High
48.88
52 Week Low
29.62
Shares Out (MIL)
147.93
Market Cap (MIL)
5,418.75
Forward P/E
--
Dividend (Yield %)
0.94

Latest Developments

More

Zhejiang Shouxiangu Pharmaceutical Plans Share Buyback

Zhejiang Shouxiangu Pharmaceutical's Controlling Shareholder To Sell 5.99% Stake

Zhejiang Shouxiangu Pharmaceutical's Controlling Shareholder Plans To Unload Up To 10% Stake In The Company

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zhejiang Shouxiangu Pharmaceuticl Co Ltd

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. is a China-based company principally engaged in the breeding, cultivation, processing and sales of traditional Chinese medicinal materials, such as the ganoderma lucidums and dendrobium officinales. The Company's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The Company mainly operates its businesses in domestic markets through wholesaling and direct sales.

Industry

Biotechnology & Drugs

Contact Info

No. 12 Huanglong 3rd Road, Wuyi County

JINHUA, ZHJ

321200

China

+86.579.87622285

http://www.sxg1909.com/

Executive Leadership

Mingyan Li

Chairman of the Board, General Manager

Huizhao Zhu

Vice Chairman of the Board

Guofang Liu

Deputy General Manager, Secretary of the Board

Ke Sun

Deputy General Manager, Director

Huaixian Zheng

Deputy General Manager, Director

Key Stats

Price To Earnings (TTM)
33.20
Price To Sales (TTM)
8.00
Price To Book (MRQ)
3.73
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
12.11
LT Debt To Equity (MRQ)
11.77
Return on Investment (TTM)
11.26
Return on Equity (TTM)
10.02

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up